{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:18:33Z","timestamp":1790835513523,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"5","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["K07CA180782"],"award-info":[{"award-number":["K07CA180782"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,1]]},"DOI":"10.1093\/jnci\/djy133","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T08:50:18Z","timestamp":1530953418000},"page":"490-497","source":"Crossref","is-referenced-by-count":94,"title":["Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck"],"prefix":"10.1093","volume":"111","author":[{"given":"Joshua M","family":"Bauml","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Michael J. Crescenz VA Medical Center, Philadelphia, PA"},{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Vinnakota","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeun-Hee","family":"Anna Park","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"},{"name":"Department of Medicine, Division of Hematology\/Oncology, The College of Physicians and Surgeons at Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Bates","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"},{"name":"Department of Medicine, Division of Hematology\/Oncology, The College of Physicians and Surgeons at Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Fojo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"},{"name":"Department of Medicine, Division of Hematology\/Oncology, The College of Physicians and Surgeons at Columbia University, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charu","family":"Aggarwal","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sewanti","family":"Limaye","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Damjanov","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Michael J. Crescenz VA Medical Center, Philadelphia, PA"},{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Di Stefano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Michael J. Crescenz VA Medical Center, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ciunci","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M","family":"Genden","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology, The Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P","family":"Wisnivesky","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine, The Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Ferrandino","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine, The Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronac","family":"Mamtani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey J","family":"Langer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger B","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Sigel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hematology\/Oncology, James J. Peters VA Medical Center, Bronx, NY"},{"name":"Department of Medicine, Division of General Internal Medicine, The Mount Sinai School of Medicine, New York, NY"},{"name":"Department of Medicine, Division of Infectious Disease, The Mount Sinai School of Medicine, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"issue":"8","key":"2019051009493802600_djy133-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/1097-0142(19900415)65:8<1685::AID-CNCR2820650804>3.0.CO;2-S","article-title":"Simultaneous versus sequential combined technique therapy for squamous cell head and neck cancer","volume":"65","author":"Adelstein","year":"1990","journal-title":"Cancer"},{"issue":"1","key":"2019051009493802600_djy133-B2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019051009493802600_djy133-B3","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1200\/JCO.2012.43.6097","article-title":"Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer","volume":"31","author":"Forastiere","year":"2013","journal-title":"J Clin Oncol"},{"issue":"19","key":"2019051009493802600_djy133-B4","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"issue":"19","key":"2019051009493802600_djy133-B5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"2019051009493802600_djy133-B6","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hed.20279","article-title":"Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)","volume":"27","author":"Bernier","year":"2005","journal-title":"Head Neck"},{"issue":"22","key":"2019051009493802600_djy133-B7","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"issue":"25","key":"2019051009493802600_djy133-B8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"issue":"4","key":"2019051009493802600_djy133-B9","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1200\/JCO.1998.16.4.1318","article-title":"Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study","volume":"16","author":"Wendt","year":"1998","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019051009493802600_djy133-B10","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0167-8140(00)00233-4","article-title":"Continuous hyperfractionated accelerated radiotherapy with\/without mitomycin C in head and neck cancers","volume":"57","author":"Dobrowsky","year":"2000","journal-title":"Radiother Oncol"},{"issue":"1","key":"2019051009493802600_djy133-B11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019051009493802600_djy133-B12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3766\/jaaa.23.7.3","article-title":"Development and validation of a cisplatin dose-ototoxicity model","volume":"23","author":"Dille","year":"2012","journal-title":"J Am Acad Audiol"},{"issue":"8","key":"2019051009493802600_djy133-B13","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br J Cancer"},{"issue":"1","key":"2019051009493802600_djy133-B14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0277-5379(83)90398-X","article-title":"Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration","volume":"19","author":"Vermorken","year":"1983","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"16","key":"2019051009493802600_djy133-B15","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1016\/j.ejca.2003.08.009","article-title":"Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose","volume":"40","author":"Li","year":"2004","journal-title":"Eur J Cancer"},{"issue":"5","key":"2019051009493802600_djy133-B16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"issue":"1","key":"2019051009493802600_djy133-B17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0167-8140(97)00048-0","article-title":"Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial","volume":"43","author":"Jeremic","year":"1997","journal-title":"Radiother Oncol"},{"issue":"8","key":"2019051009493802600_djy133-B18","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","article-title":"Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial","volume":"20","author":"Chan","year":"2002","journal-title":"J Clin Oncol"},{"issue":"7","key":"2019051009493802600_djy133-B19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"2019051009493802600_djy133-B20","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.ijrobp.2007.12.028","article-title":"Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of China","volume":"71","author":"Chen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2019051009493802600_djy133-B21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/hed.20111","article-title":"Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer","volume":"27","author":"Beckmann","year":"2005","journal-title":"Head Neck"},{"issue":"1","key":"2019051009493802600_djy133-B22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.radonc.2006.03.010","article-title":"A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas","volume":"79","author":"Medina","year":"2006","journal-title":"Radiother Oncol"},{"issue":"11A","key":"2019051009493802600_djy133-B23","first-page":"163","article-title":"NCCN practice guidelines for head and neck cancers","volume":"14","author":"Pfister","year":"2000","journal-title":"Oncology (Williston Park)"},{"key":"2019051009493802600_djy133-B24","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1200\/JCO.2017.35.15_suppl.6006","article-title":"Concurrent chemoradiotherapy with 3-weekly versus weekly cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial (ChiCTR-TRC-12001979)","volume":"35(15_suppl)","author":"Liang","year":"2017","journal-title":"J Clin Oncol"},{"key":"2019051009493802600_djy133-B25","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.35.15_suppl.6007","article-title":"Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial","author":"Noronha","year":"2017","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019051009493802600_djy133-B26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnci\/djq549","article-title":"A population-based assessment of specialty physician involvement in cancer clinical trials","volume":"103","author":"Klabunde","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2019051009493802600_djy133-B27","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2014.32.15_suppl.7564","article-title":"Cisplatin and etoposide versus carboplatin and paclitaxel with concurrent radiotherapy for stage III non-small-cell lung cancer: an analysis of Veterans Health Administration data","author":"Santana-Davila","year":"2014","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019051009493802600_djy133-B28","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2019051009493802600_djy133-B29","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/ntr\/ntr206","article-title":"Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source","volume":"13","author":"McGinnis","year":"2011","journal-title":"Nicotine Tob Res"},{"key":"2019051009493802600_djy133-B30","first-page":"IV-49","article-title":"Studying radiation therapy using SEER-Medicare-linked data","volume":"40(8 suppl)","author":"Virnig","year":"2002","journal-title":"Med Care"},{"issue":"3","key":"2019051009493802600_djy133-B31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2019051009493802600_djy133-B32","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2017.73.8245","article-title":"Starting dose of sorafenib for the treatment of hepatocellular carcinoma: a retrospective, multi-institutional study","author":"Reiss","year":"2017","journal-title":"J Clin Oncol"},{"key":"2019051009493802600_djy133-B33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.ejca.2016.08.013","article-title":"Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma","volume":"67","author":"Spreafico","year":"2016","journal-title":"Eur J Cancer"},{"key":"2019051009493802600_djy133-B34","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2017-0015","article-title":"Weekly low\u2010dose versus three\u2010weekly high\u2010dose cisplatin for concurrent chemoradiation in locoregionally advanced non\u2010nasopharyngeal head and neck cancer: a systematic review and meta\u2010analysis of aggregate data","author":"Szturz","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"2019051009493802600_djy133-B35","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1200\/JCO.2013.53.8009","article-title":"American Society of Clinical Oncology perspective: raising the bar for clinical trials by defining clinically meaningful outcomes","volume":"32","author":"Ellis","year":"2014","journal-title":"J Clin Oncol"},{"issue":"2","key":"2019051009493802600_djy133-B36","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0167-8140(00)00203-6","article-title":"Combined chemoradiotherapy with daily low-dose cisplatin in locally advanced inoperable non-small cell lung cancer","volume":"56","author":"Biedermann","year":"2000","journal-title":"Radiother Oncol"},{"issue":"2","key":"2019051009493802600_djy133-B37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"issue":"2","key":"2019051009493802600_djy133-B38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0360-3016(91)90098-O","article-title":"Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial","volume":"20","author":"Bachaud","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"2019051009493802600_djy133-B39","doi-asserted-by":"crossref","first-page":"e2950.","DOI":"10.1097\/MD.0000000000002950","article-title":"Incidence and outcomes of patients with oral cavity squamous cell carcinoma and fourth primary tumors: a long-term follow-up study in a betel quid chewing endemic area","volume":"95","author":"Adel","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2019051009493802600_djy133-B40","doi-asserted-by":"crossref","first-page":"e2017009","DOI":"10.4178\/epih.e2017009","article-title":"Smokeless tobacco (paan and gutkha) consumption, prevalence, and contribution to oral cancer","volume":"39","author":"Niaz","year":"2017","journal-title":"Epidemiol Health"},{"issue":"6","key":"2019051009493802600_djy133-B41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.6004\/jnccn.2017.0101","article-title":"NCCN guidelines insights: head and neck cancers, version 2.2017","volume":"15","author":"Adelstein","year":"2017","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"2019051009493802600_djy133-B42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.28558","article-title":"Early outpatient follow-up and 30-day outcomes in patients hospitalized with cirrhosis","volume":"64","author":"Kanwal","year":"2016","journal-title":"Hepatology"},{"issue":"16","key":"2019051009493802600_djy133-B43","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1093\/jnci\/djj305","article-title":"Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer","volume":"98","author":"Hassett","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"8 suppl","key":"2019051009493802600_djy133-B44","first-page":"IV-62","article-title":"Measuring complications of cancer treatment using the SEER-Medicare data","volume":"40","author":"Potosky","year":"2002","journal-title":"Med Care"},{"issue":"24","key":"2019051009493802600_djy133-B45","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1200\/JCO.2002.05.088","article-title":"Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancer","volume":"20","author":"Du","year":"2002","journal-title":"J Clin Oncol"},{"key":"2019051009493802600_djy133-B46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med."},{"issue":"21","key":"2019051009493802600_djy133-B47","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1001\/archinte.160.21.3252","article-title":"Are patients at Veterans Affairs medical centers sicker? A comparative analysis of health status and medical resource use","volume":"160","author":"Agha","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/111\/5\/490\/28580411\/djy133.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T09:50:16Z","timestamp":1557481816000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article\/111\/5\/490\/5101450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,9,18]]},"published-print":{"date-parts":[[2019,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djy133","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,5]]},"published":{"date-parts":[[2018,9,18]]}}}